<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
<Article>
<Journal>
<PublisherName>jmedicalcasereports</PublisherName>
<JournalTitle>Frontiers in Medical Case Reports</JournalTitle>
<PISSN>I</PISSN>
<EISSN>S</EISSN>
<Volume-Issue>Volume 2; Issue 1, (Jan-Jun,2021)</Volume-Issue>
<PartNumber/>
<IssueTopic>Multidisciplinary</IssueTopic>
<IssueLanguage>English</IssueLanguage>
<Season>Cancer Case Reports</Season>
<SpecialIssue>N</SpecialIssue>
<SupplementaryIssue>N</SupplementaryIssue>
<IssueOA>Y</IssueOA>
<PubDate>
<Year>-0001</Year>
<Month>11</Month>
<Day>30</Day>
</PubDate>
<ArticleType>Cancer Case Reports</ArticleType>
<ArticleTitle>Mitochondrial DNA (mtDNA) and Cancer Pathogenesis - The Role of mtDNA Mutations: A Review</ArticleTitle>
<SubTitle/>
<ArticleLanguage>English</ArticleLanguage>
<ArticleOA>Y</ArticleOA>
<FirstPage>1</FirstPage>
<LastPage>26</LastPage>
<AuthorList>
<Author>
<FirstName>Nikolaos Andreas</FirstName>
<LastName>Chrysanthakopoulos</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>N</CorrespondingAuthor>
<ORCID/>
</Author>
</AuthorList>
<DOI/>
<Abstract>Mitochondria are essential metabolic organelles as produce cellular energy by oxidative phosphorylation (OXPHOS), produce reactive oxygen species (ROS) as a by-product, and regulate functions such as apoptosis via the mitochondrial permeability transition pore (mtPTP). However, mitochondria are also responsible for multiple cellular functions such as, cellular development, growth, signals interaction from mitochondria to nucleus and nucleus to mitochondria, and are involved in miscellaneous metabolic pathways.
Those processes are accomplished by several protein complexes and mitochondrial respiratory chains (MRC) encoded by nuclear and mitochondrial DNA (mtDNA), as are assembled from both nuclear DNA (nDNA) and mitochondrial DNA genes. The mt DNA is a circular, double-stranded molecule 16,569 base pairs (bp) in length, contains 37 genes which code 13 polypeptides, 2 genes of rRNA (12S,16S), and 22 genes of tRNA, and is present in thousands of copies in each human cell. Almost 90 years ago, Otto Warburg hypothesized that a defect in energy metabolism is the initial cause of cancer. Mitochondria have also active roles in a diversity of other processes, including inflammation, whereas their functions seem to influence some of cancer hallmarks, which include evasion of cell death, genome instability, tumor-promoting inflammation and metastasis. Defects in mitochondrial function which are associated with bioenergetic deficiencies can lead to nDNA genome instability, resistance to apoptosis and induction of NADPH oxidase which is implicated in ROS production. Researches have demonstrated that mtDNA shows a high mutations rate most of which are responsible for mild mitochondrial dysfunction and its essential role in tumorigenesis, whereas enhanced mitochondrial biogenesis is frequently recorded in cancer cells. Although mtDNA has been implicated in cancer pathogenesis, its role remains to be defined. The aim of the current article was to examine the role of mtDNA mutations in cancer pathogenesis.</Abstract>
<AbstractLanguage>English</AbstractLanguage>
<Keywords>Mitochondria,mt DNA,Mutations,Cancer,Polymorphism</Keywords>
<URLs>
<Abstract>https://jmedicalcasereports.org/ubijournal-v1copy/journals/abstract.php?article_id=15141&title=Mitochondrial DNA (mtDNA) and Cancer Pathogenesis - The Role of mtDNA Mutations: A Review</Abstract>
</URLs>
<References>
<ReferencesarticleTitle>References</ReferencesarticleTitle>
<ReferencesfirstPage>16</ReferencesfirstPage>
<ReferenceslastPage>19</ReferenceslastPage>
<References>Ahn EH, Hirohata K, Kohrn BF, Fox EJ, Chang CC, Loeb LA. Detection of ultrarare mitochondrial mutations in breast stem cells by duplex sequencing. PLoS One 2015; 10: e0136216.
Akhmedov AT and Marand;iacute;n-Garcand;iacute;a J. Mitochondrial DNA maintenance: An appraisal. Mol Cell Bio-chem 2015; 409: 283-305.
Akimoto M, Niikura M, Ichikawa M, Yonekawa H, Nakada K, Honma Y, Hayashi Y-Iet. Nuclear DNA but not mtDNA controls tumor phenotypes in mouse cells. Biochem Biophys Res Commun 2005; 327: 1028–1035.
Anderson S, Bankier AT, Barrell BG, de Bruijn MHL,Coulson AR, Drouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F, Schreier PH, Smith AJH, Staden R, Young IG. Sequence and organization of the human mitochondrial genome. Nature 1981; 290: 457-465.
Arnold RS, Sun CQ, Richards JC, Grigoriev G, Coleman IM, Nelson PS, Hsieh C-L, Lee JK, Xu Z, Rogatko A, Osunkoya AO, Zayzafoon M, Chung L, Petros JA. Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment. Prostate 2009; 69: 1–11.
Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, Skand;ouml;ldberg F,Husebye ES,Eng C, Maher ER. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001; 69: 49–54.
Attardi G, Yoneda M, Chomyn A. Complementation and segregation behavior of disease-causing mitochondrial DNA mutations in cellular model systems. Biochim Biophys Acta 1995; 1271: 241-248.
Augenlicht LH and Heerdt BG. Mitochondria: integrators in tumorigenesis? Nat Genet 2001; 28: 104-105.
Bai RK, Leal SM, Covarrubias D, Liu A, Wong LJ. Mitochondrial genetic background modifies breast cancer risk. Cancer Res 2007; 67: 4687-4694.
Bayley JP, van Minderhout I, Weiss MM, Jansen JC, Oomen PH, Menko FH, Pasini B, Ferrando B, Wong N, Alpert LC. Mutation analysis of SDHB and SDHC: novel Germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma. BMC Med Genet 2006; 7: 1.
Bianchi NO, Bianchi MS, Richard SM. Mitochondrial genome instability in human cancers. Mutat Res 2001; 488: 9-23.
Bielas JH and Loeb LA. Mutator phenotype in cancer: timing and perspectives. Environ Mol Mutagen 2005; 45: 206-213.
Biswas G, Anandatheerthavarada HK, Zaidi M, Avadhani NG. Mitochondria to nucleus stress signaling: a distinctive mechanism of NFkappaB/Rel activation through calcineurin-mediated inactivation of IkappaBbeta. J Cell Biol 2003; 161: 507-519.
Blein S, Bardel C, Danjean V, McGu?og L, Healey S, Barrowdale D, Lee A ,Dennis J, Kuchenbaecker KB, Soucy P,Beth Terry M, Chung WK,Goldgar DE, Buys SS,Breast Cancer Family Registry: Janavicius R, et al. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers. Breast Cancer Res 2015, 17: 61.
Booker LM, Habermacher GM, Jessie BC, Sun QC, Baumann AK, Amin M, Lim SD, Fernan-dez-Golarz C, Lyles RH, Brown MD, Marshall FF, Petros JA. North American white mitochondrial haplogroups in prostate and renal cancer. J Urol 2006;175: 468-473.
Brandon M, Baldi P, Wallace DC. Mitochondrial mutations in cancer. Oncogene 2006; 25: 4647-4662.
Burnichon N, Briand;egrave;re JJ, Liband;eacute; R, Vescovo L, Riviand;egrave;re J, Tissier F, Jouanno E, Jeunemaitre X, Band;eacute;nit P, Tzagoloff A, Rustin P, Bertherat J, Favier J, Gimenez-Roqueplo AP. SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet 2010; 19: 3011-3020.
Cano D, Gomez CF, Ospina N, Cajigas JA, Groot H, Andrade RE. Torres MM: Mitochondrial DNA haplogroups and susceptibility to prostate cancer in a Colombian population. ISRN Oncol 2014: 530675.
Canter JA, Kallianpur AR, Parl FF, Millikan RC. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res 2005; 65: 8028-8033.
Chinnery PF, Samuels DC, Elson J, Turnbull DM. Lancet 2002; 360: 1323-1325.
Coller HA, Khrapko K, Bodyak ND, Nekhaeva E, Herrero-Jimenez P, Thilly WG. High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat Genet 2001; 28: 147-150.
Cook CC, Kim A, Terao S, Gotoh A, Higuchi M. Consumption of oxygen: a mitochondrial generated progression signal of advanced cancer. Cell Death Dis 2012; 3: e258.
Copeland WC, Wachsman JT, Johnson FM, Penta JS. Mitochondrial DNA alterations in cancer. Cancer Invest 2002; 20: 557–569.
Coskun PE, Beal MF, Wallace DC. Alzheimer’s brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc Natl Acad Sci USA 2004; 101: 10726-10731.
Czarnecka AM, Golik P, Bartnik E. Mitochondrial DNA mutations in human neoplasia. J Appl Genet 2006; 47: 67-78.
Czarnecka M and Bartnik E. Mitochondrial DNA mutations in tumors. In: Cellular Respiration and Carcinogenesis. Apte SP and Sarangarajan R (eds). Humana Press, New York. 2009; pp: 119-130.
Czarnecka AM, Krawczyk T, Zdro?ny M, Lubi?ski J, Arnold RS, Kukwa W, Sci?ska A, Golik P, Bartnik E, Petros JA. Mitochondrial NADH-dehydrogenase subunit3(ND3) polymorphism (A10398G) and sporadic breast cancer in Poland. Breast Cancer Res Treat 2010; 121: 511-518.
Czarnecka AM, Krawczyk T, Plak K, Klemba A, Zdrozny M, Arnold RS, Ko?er B, Golik P, Szybinska A, Lubinski J, Mossakowska M, Bartnik E, Petros JA. Mitochondrial genotype and breast cancer predisposition. Oncol Rep 2010; 24: 1521-1534.
Czarnecka AM and Bartnik E. The role of the mitochondrial genome in ageing and carcinogenesis. J Aging Res 2011; 136435.
Darvishi K, Sharma S, Bhat AK, Rai E, Bamezai RN. Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer. Cancer Lett 2007; 249: 249-255.
Dasgupta S, Hoque MO, Upadhyay S, Sidransky D. Mitochondrial cytochrome B gene mutation promotes tumor growth in bladder cancer. Cancer Res 2008; 68: 700-706.
Dasgupta S, Hoque MO, Upadhyay S, Sidransky D. Forced cytochrome B gene mutation expression induces mitochondrial proliferation and prevents apoptosis in human uroepithelial SV-HUC -1 cells. Int J Cancer 2009; 125: 2829-2835.
Delsite RL, Rasmussen LJ, Rasmussen AK, Kalen A, Goswami PC, Singh KK. Mitochondrial impairment is accompanied by impaired oxidative DNA repair in the nucleus. Mutagenesis 2003; 18: 497-503.
Desouki MM, Kulawiec M, Bansal S, Das GM, Singh KK. Crosstalk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors. Cancer Biol Ther 2005; 4: 1367-1373
Dimauro S and Davidzon G. Mitochondrial DNA and disease. Ann Med 2005; 37: 222–232.
Downward J. Targeting RAS signaling pathways in cancer therapy. Nat Rev Cancer 2003; 3: 11–22.
Egea PF, Stroud RM, Walter P: Targeting proteins to membranes: Structure of the signal recognition particle. Curr Opin Struct Biol 2005; 15: 213-220.
Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007; 35: 495-516.
Fang H, Shen L, Chen T, He J, Ding Z, Wei J, Qu J, Chen G, Lu J, Bai Y. Cancer type-specific modulation of mitochondrial haplogroups in breast, colorectal and thyroid cancer. BMC Cancer 2010: 421.
Fernand;aacute;ndez-Silva P, Enriquez JA, Montoya J. Replication and transcription of mammalian mitochondrial DNA. Exp Physiol 2003; 88: 41-56.
Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, Jen J, Sidransky D: Facile detection of mitochondrial DNA mutations in tumors and bodily ?uids. Science 2000; 287: 2017- 2019.
Formentini L, Martinez-Reyes I, Cuezva JM. The mitochondrial bioenergetic capacity of carcinomas. IUBMB Life 2010; 62: 554-560.
Gaude E and Frezza, C. Defects in mitochondrial metabolism and cancer. Cancer Metab 2014; 2: 10.
Giompazolias E and Tait SW. Mitochondria and the hallmarks of cancer. FEBS J 2016 283: 803-814.
Guaragnella N, Giannattasio S, Moro L. Mitochondrial dysfunction in cancer chemoresistance. BioChem Pharmacol 2014; 92: 62-72.
Guerra F, Guaragnella N, Arbini AA, Bucci C, Giannattasio S, Moro L. Mitochondrial Dysfunction: A Novel Potential Driver of Epithelial-to-Mesenchymal Transition in Cancer. Front Oncol 2017; 7: 295.
Guha M, Fang JK, Monks R, Birnbaum MJ, Avadhani NG. Activation of Akt is essential for the propagation of mitochondrial respiratory stress signaling and activation of the transcriptional coactivator heterogeneous ribonucleoprotein A2. Mol Biol Cell 2010a; 21: 3578–3589.
Guo J, Zheng L, Liu W, Wang X, Wang Z, Wang Z, French AJ, Kang D, Chen L, Thibodeau SN, Liu W. Frequent truncating mutation of TFAM induces mitochondrial DNA depletion and apoptotic resistance in microsatellite- unstable colorectal cancer. Cancer Res 2011; 71: 2978–2987.
Hanahan D and Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144: 646-674.
He Y, Wu J, Dressman DC, Iacobuzio-Donahue C, Markowitz SD, Velculescu VE, Diaz Jr LA, Kinzler KW, Vogelstein B, Papadopoulos N. Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. Nature 2010; 464: 610–614.
Higuchi M, Aggarwal BB, Yeh ET. Activation of CPP32-like protease in tumor necrosis factor induced apoptosis is dependent on mitochondrial function. J Clin Invest 1997; 99: 1751–1758.
Higuchi M, Kudo T, Suzuki S, Evans TT, Sasaki R, Wada Y,Shirakawa T, Sawyer JR, Gotoh A. Mitochondrial DNA determines androgen dependence in prostate cancer cell lines. Oncogene 2006; 25: 1437–1445.
Higuchi M, Manna SK, Sasaki R, Aggarwal BB. Regulation of the Activation of Nuclear Factor kappaB by Mitochondrial Respiratory Function: Evidence for the Reactive Oxygen Species Dependent and -Independent Pathways. Antioxid Redox Signal 2002; 4: 945–955.
Hofhaus G and Gattermann N. Mitochondria harbouring mutant mtDNA-a cuckoo in the nest? Biol Chem 1999; 380: 871-877.
Horton TM, Petros JA, Heddi A, Shoffner J, Kaufman AE, Graham Jr SD, Gramlich T, Wallace DC. Novel mitochondrial DNA deletion found in a renal cell carcinoma. Gen Chrom Cancer 1996; 15: 95–101.
Huanzheng Li, Jesse Slone, Lin Fei, Taosheng Huang. Mitochondrial DNA Variants and Common Diseases: A Mathematical Model for the Diversity of Age-Related mtDNA Mutations. Cells 2019; 8: 608.
Hu SP, Du JP, Li DR, Yao YG. Mitochondrial DNA haplogroup confers genetic susceptibility to nasopharyngeal carcinoma in Chaoshanese from Guangdong, China. PLoS One 2014; 9: e87795.
Iommarini L, Kurelac I, Capristo M, Calvaruso MA, Giorgio V, Bergamini C, GhelliA, Nanni P, Giovanni CDe, Carelli V, Fato R, Lollini PL, Rugolo M, Gasparre G, Porcelli AM. Di?erent mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairment. Hum Mol Genet 2014; 23: 1453–1466.
Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, Honma Y, Hayashi JI. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 2008; 320: 661–664.
Yeh JJ, Lunetta KL, van Orsouw NJ, Moore Jr FD, Mutter GL, Vijg J,Dahia PLM, Eng C. Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours. Oncogene 2000; 19: 2060-2066.
Jiang J, Zhao JH, Wang XL, Di JI, Liu ZB, Li GY, Wang MZ, Li Y, Chen R, Ge RL. Analysis of mitochondrial DNA inTibetan gastric cancer patients at high altitude. Mol Clin Oncol 2015; 3: 875-879.
Ju YS, Alexandrov LB, Gerstung M, Martincorena I, Nik-Zainal S, Ramakrishna M, Davies HR, Papa-emmanuil E, Gundem G, Shlien A, Bolli N, Behjati S, Tarpey PS, Nangalia J, Massie CE, Butler AP, Teague JW. Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer. Elife 2014; 3: 02935.
Kamp WM, Wang PY, Hwang PM. TP53 mutation, mitochondria and cancer. Curr Opin Genet Dev 2016; 38: 16-22.
Khrapko K, Coller HA, Andre PC, Li XC, Hanekamp JS, Tilly WG. Mitochondrial mutational spectra in human cells and tissues. Proc Natl Acad Sci USA 1997; 94: 13798-13803.
Kirches E, Krause G, Warich-Kirches M, Weis S, Schneider T, Meyer-Puttlitz B, Mawrin C, Dietzmann K. High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples. Int J Cancer 2001; 93: 534-538.
Kirches E. Mitochondrial and nuclear genes of mitochondrial components in cancer. Curr Genomics 2009; 10: 281-293.
Kloss-Brandstatter A, Weissensteiner H, Erhart G, Schafer G, Forer L, Schonherr S, Pacher D, Seifarth C, Stand;ouml;cklA, Fendt L, Sottsas I, Klocker H, Huck CW, Rasse M, Kronenberg F, Kloss FR.Validation of next-generation sequencing of entire mitochondrial genomes and the diversity of mitochondrial DNA mutations in oral squamous cell carcinoma. PLoS One 2015; 10: e0135643.
Kumimoto Y, Yamane Y Nishimoto H, Fukami M, Shinoda S, Hatooka K, Ishizaki K. Frequent somatic mutations of mitochondrial DNA in esophageal squamous cell carcinoma. Int J Cancer 2004; 108: 228-231.
Kuo SJ, Chen M, Ma GC, Chen ST, Chang SP, Lin WY, Chen YC, Lee TH, Lin TT, Liu CS. Number of somatic mutations in the mitochondrial D-loop region indicates poor prognosis in breast cancer, independent of TP53 mutation. Cancer Genet Cytogenet 2010; 201: 94-101.
Kurelac I, MacKay A, Lambros MB, Di Cesare E, Cenacchi G, Ceccarelli C, Morra I, Melcarne A, Morandi L, Calabrese FM, Attimonelli M, Tallini G, Reis-Filho JS, Gasparre G. Somatic complex I disruptive mitochondrial DNA mutations are modifiers of tumorigenesis that correlate with low genomic instability in pituitary adenomas. Hum Mol Genet 2013; 22: 226-238.
Kurtz A, Lueth M, Kluwe L, Zhang T, Foster R, Mautner VF, Hartmann M, Tan DJ, Martuza RL, Friedrich RE, Driever PH, Wong LJ C. Somatic Mitochondrial DNA Mutations in Neurofibromatosis Type 1-Associated Tumors. Mol Cancer Res 2004; 2: 433-441.
Lam ET, Bracci PM, Holly EA, Chu C, Poon A, Wan E, White K, Kwok PY, Pawlikowska L, Tranah GJ. Mitochondrial DNA sequence variation and risk of pancreatic cancer. Cancer Res 2012; 72: 686-695.
Larman TC, DePalma SR, Hadjipanayis AG, Protopopov A, Zhang J, Gabriel SB, Chin L, Seidman CE, Kucherlapati R and Seidman JG; Cancer Genome Atlas Research Network: Spectrum of somatic mitochondrial mutations in five cancers. Proc Natl Acad Sci USA 2012; 109: 14087-14091.
Lee WTY, Cain JE, Cuddihy A, Johnson J, Dickinson A, Yeung K-Y, Kumar B, Johns TG, Watkins DN, Spencer A, John JCSt. Mitochondrial DNA plasticity is an essential inducer of tumorigenesis. Cell Death Discovery 2016; 2: 1-11.
Lee HC, Li SH, Lin JC, Wu CC, Yeh DC, Wei YH. Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutat Res 2004; 547: 71-78.
Lee HC, Yin PH, Lin JC, Wu CC, Chen CY, Wu CW, Chi CW, Tam TN, Wei YH. Mitochondrial genome instability and mtDNA depletion in human cancers. Ann N Y Acad Sci 2005; 1042: 109-122.
Lehtonen R, Husgafvel-Pursiainen K, Isola J, Jand;auml;rvinen H, Koivisto P, Kiuru M, Vanharanta S, Sjand;ouml;berg J, Aaltonen LM, Aittomaki K, Arola J, Butzow R, Eng C. Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors. Am J Pathol 2004; 164: 17-22.
Li Y, Beckman KB, Caberto C, Kazma R, Lum-Jones A, Haiman CA, Le Marchand L, Stram DO, Saxena R, Cheng I: Association of genes, pathways, and haplogroups of the mitochondrial genome with the risk of colorectal cancer: The multiethnic Cohort. PLoS One 2015; 10: e0136796.
Liang BC and Hays L. Mitochondrial DNA copy number changes in human gliomas. Cancer Lett 1996; 105: 167-173.
Linkowska K, Jawien A, Marszalek A, Malyarchuk BA, Tonska K, Bartnik E, Skonieczna K, Grzybowski T. Mitochondrial DNA polymerase gamma mutations and their implications in mtDNA alterations in colorectal cancer. Ann Hum Genet 2015; 79: 320-328.
Liou CW, Lin TK, Chen JB, Tiao MM, Weng SW, Chen SD, Chuang YC, Chuang JH, Wang PW. Association between a common mitochondrial DNA D-loop polycytosine variant and alteration of mitochondrial copy number in human peripheral blood cells. J Med Genet 2010; 47: 723-728.
Liu VW, Wang Y, Yang HJ, Tsang PCK,Ng TY, Wong L-C, Nagley P, Ngan HYS. Mitochondrial DNA variant 16189T>C is associated with susceptibility to endometrial cancer. Hum Mutat 2003; 22: 173-174.
Liu VW, Shi HH, Cheung AN, Chiu PM,Leung TW, Nagley P, Wong LC, Ngan HY. High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res 2001; 61: 5998-6001.
Lynch SM, Weinstein SJ, Virtamo J, Lan Q, Liu CS, Cheng WL, Rothman N, Albanes D, Stolzenberg-. Solomon RZ. Mitochondrial DNA copy number and pancreatic cancer in the alpha-tocopherol beta-carotene cancer prevention study. Cancer Prev Res (Phila) 2011; 4: 1912-1919.
Mancuso M, Filosto M, Choub A, Tentorio M, Broglio L, Padovani A, Siciliano G. Mitochondrial DNA-related disorders. Biosci Rep 2007; 27: 31-37.
Mand;aacute;ximo V, Soares P, Lima J, Cameselle-Teijeiro J, Manuel Sobrinho-Simand;otilde;es M. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hand;uuml;rthle cell tumors. Am J Pathol 2002; 160: 1857-1865.
Masuda S, Kadowaki T, Kumaki N, Tang X, Tokuda Y, Yoshimura S, Takekoshi S, Osamura RY. Analysis of gene alterations of mitochondrial DNA D-loop regions to determine breast cancer clonality. Br J Cancer 2012; 107: 2016-2023.
Modica-Napolitano JS and Singh K. Mitochondria as targets for detection and treatment of cancer. Expert Rev Mol Med 2002; 4: 1-19.
Modica-Napolitano JS, Kulawiec M, Singh KK: Mitochondria and human cancer. Curr Mol Med 2007; 7: 121-131.
Modica-Napolitano JS and Singh KK. Mitochondrial dysfunction in cancer. Mitochondrion 2004; 4: 755–762.
McMahon S and La Framboise T. Mutational patterns in the breast cancer mitochondrial genome, with clinical correlates. Carcinogenesis 2014; 35: 1046-1054.
Naito Akihiro, Mizumachi Takatsugu, Wang Mian, Xie Cheng-hui, Evans T Teresa, Thomas J Kelly, Masahiro Higuchi. Progressive tumor features accompany epithelial-mesenchymal transition induced in mitochondrial DNA depleted cells. Cancer Sci 2008; 99: 1584-1588.
Neupert W and Herrmann JM: Translocation of proteins into mitochondria. Annu Rev Biochem 2007; 76: 723-749.
Nomoto S, Yamashita K, Koshikawa K, Nakao A, Sidransky D. Mitochondrial D-loop Mutations As Clonal Markers in Multicentric Hepatocellular Carcinoma and Plasma. Clin Cancer Res 2002; 8: 481-487.
Nguyen AD, McDonald JG, Bruick RK, DeBose-Boyd RA. Hypoxia stimulates degradation of 3- hydroxy-3-methylglutaryl-coenzyme A reductase through accumulation of lanosterol and hypoxiainducible factor-mediated induction of insigs. J Biol Chem 2007; 282: 27436-27446.
Nicholls TJ and Minczuk M. In D-loop: 40 years of mitochondrial 7S DNA. Exp Gerontol 2014; 56: 175-181.
Nishimura G, Proske RJ, Doyama H, Higuchi M. Regulation of apoptosis by respiration: cytochrome c release by respiratory substrates. FEBS Lett 2001; 505: 399-404.
Okochi O, Hibi K, Uemura T, Inoue S, Takeda S, Kaneko T. Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients. Clin Cancer Res 2002; 8: 2875-2878.
Pagliarini DJ, Calvo SE, Chang B, Sheth SA, Vafai SB, Ong SE, Walford GA,Sugiana C,Boneh A, Chen WK, Hill DE, Vidal M, Evans JG, Thorburn DR, Carr SA, Mootha VK. A mitochondrial protein compendium elucidates complex I disease biology. Cell 2008; 134: 112-123.
Park SY, Chang I, Kim JY, Kang SW, Park SH, Singh K, Lee MS. Resistance of mitochondrial DNA depleted cells against cell death: Role of mitochondrial superoxide dismutase. J Biol Chem 2004; 279: 7512-7520.
Parker SJ and Metallo CM. Metabolic consequences of oncogenic IDH mutations. Pharmacol Ther 2015; 152: 54-62.
Pelicano H, Xu RH, Du M, Feng L, Sasaki R, Carew JS,Hu Y,Ramdas L, Hu L,Keating MJ,Zhang W, Plunkett W, Huang P. Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J Cell Biol 2006; 175: 913-923.
Peng TI, Yu PR, Chen JY, Wang HL, Wu HY, Wei YH, Jou MJ. Visualizing common deletion of mitochondrial DNA-augmented mitochondrial reactive oxygen species generation and apoptosis upon oxidative stress. Biochim Biophys Acta 2006; 1762: 241-255.
Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, Lim S, Issa MM, Flanders WD, Hosseini SH, Marshall FF, Wallace DC. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 2005; 102: 719-724.
Polyak K, Li Y, Zhu H, Lengauer C, Willson JKV, Markowitz SD, Trush MA,Kinzler KW, Vogelstein B. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 1998; 20: 291-293.
Poynter JN, Richardson M, Langer E, Hooten AJ, Roesler M, Hirsch B, Nguyen PL, Cioc A, Warlick E, Ross JA. Association between mitochondrial DNA haplogroup and myelodysplastic syndromes. Gen Chrom Cancer 2016; 55: 688-693.
Qu F, Liu X, Zhou F, Yang H, Bao G, He X and Xing J. Association between mitochondrial DNA content in leukocytes and colorectal cancer risk. Cancer 2011; 117: 3148-3155.
Rasmussen AK, Chatterjee A, Rasmussen LJ, Singh KK. Mitochondria-mediated nuclear mutator phenotype in Saccharomyces cerevisiae. Nucleic Acids Res 2003; 31: 3909-3917.
Reid R. Can migratory mitochondria DNA activate oncogenes? Trends Biochem Sci 1983; 8: 190-191.
Reitman ZJ, Jin G, Karoly ED, Spasojevic I, Yang J, Kinzler KW, He Y, Bigner DD, Vogelstein B, Yan H. Profling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome. Proc Natl Acad Sci USA 2011; 108: 3270-3275.
Reznik E, Miller ML, ?enbabao?lu Y, Riaz N, Sarungbam J, Tickoo SK, Al-Ahmadie HA, Lee W, Seshan VE, Hakimi AA, Sander C. Mitochondrial DNA copy number variation across human cancers. Elife 2016; 5: e10769.
Rogalinska M. The role of mitochondria in cancer induction, progression and changes in metabolism. Mini Rev Med Chem 2016; 16: 524-530.
Salgado J, Honorato B, Garcia-Foncillas J. Review: mitochondrial defects in breast cancer. Clin Med Oncol 2008; 2: 199-207.
Savagner F, Franc B, Guyetant S, Rodien P, Reynier P, Malthiery Y. Defective mitochondrial ATP synthesis in oxyphilic thyroid tumors. J Clin Endocrinol Metab 2001; 86: 4920–4925.
Senf D and Ronai ZA. Regulators of mitochondrial dynamics in cancer. Curr Opin Cell Biol 2016; 39: 43-52.
Shay JW and Werbin H. New evidence for the insertion of mitochondrial DNA into the human genome: significance for cancer and aging. Mutat Res 1992; 275: 227-235.
Shidara Y, Yamagata K, Kanamori T, Nakano K, Kwong JQ, Manfredi G,Oda H, Ohta S. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res 2005; 65: 1655-1663.
Singh KK. Mitochondrial damage checkpoint in apoptosis and genome stability. FEMS Yeast Res 2004; 2: 127-132.
Singh KK and Kulawiec M. Mitochondrial DNA polymorphism and risk of cancer. Methods Mol Biol 2009; 471: 291-303, 2009.
Singh B, Owens KM, Bajpai P, Desouki MM, Srinivasasainagendra V, Tiwari HK, Singh KK Mitochondrial DNA polymerase POLG1 disease mutations and germline variants promote tumorigenic properties. PLoS One 2015; 10: e0139846.
Song BL, Javitt NB, DeBose-Boyd RA. Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol. Cell Metab 2005; 1: 179-189.
Stefano GB and Kream RM. Cancer: mitochondrial origins. Med Sci Monitor 2015; 21: 3736-3739.
Stefano GB and Kream RM. Mitochondrial DNA heteroplasmy in human health and disease. Biomed Rep 2016; 4: 259-262.
Stewart JB and Chinnery PF. The dynamics of mitochondrial DNA heteroplasmy: Implications for human health and disease. Nat Rev Genet 2015; 16: 530-542.
Stoneking M. Hypervariable sites in the mtDNA control region are mutational hotspots. Am J Hum Genet 2000; 67: 1029-1032.
Su X, Wang W, Ruan G, Liang M, Zheng J, Chen Y, Wu H, Fahey TJ III, Guan M and Teng L: A comprehensive characterization of mitochondrial genome in papillary thyroid cancer. Int J Mol Sci 2016; 17: 1594.
Sui G, Zhou S, Wang J, Canto M,Lee EE, Eshleman JR, Montgomery EA, Sidransky D, Califano JA, Maitra A. Mitochondrial DNA mutations in preneoplastic lesions of the gastrointestinal tract: a biomarker for the early detection of cancer. Mol Cancer 2006; 5: 73.
Suzuki S, Naito A, Asano T, Evans TT, Reddy SA, Higuchi M. Constitutive Activation of AKT Pathway Inhibits TNF-induced Apoptosis in Mitochondrial DNA-Deficient human myelogenous leukemia ML-1a. Cancer Lett 2008; 268: 31-37.
van Gisbergen MW, Voets AM, Starmans MH, de Coo IF, Yadak R, Hoffmann RF, Boutros PC, Smeets HJ, Dubois L and Lambin P: How do changes in the mtDNA and mitochondrial dysfunction in?uence cancer and cancer therapy? Challenges, opportunities and models. Mutat Res Rev Mutat Res 2015; 764: 16-30.
van Oven M. PhyloTree Build 17: growing the human mitochondrial DNA tree. Forensic Sci Int Genet Suppl Ser 2015; 5: e392-394.
Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324: 1029-1033.
Vanharanta S, Buchta M, McWhinney SR, Virta SK, Peczkowska M, Morrison CD, Lehtonen R,Januszewicz A, Jand;auml;rvinen H,Juhola M,Mecklin J-P, Pukkala E, Herva R, Kiuru M, Nupponen NN, Aaltonen LA, Neumann HPH, Eng C. Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. Am J Hum Genet 2004;74: 153-159.
Verma M, Naviaux RK, Tanaka M, Kumar D, Franceschi C, Singh KK. Meeting report: Mitochondrial DNA and cancer epidemiology. Cancer Res 2007;67: 437-439.
Vyas S, Zaganjor E, Haigis MC. Mitochondria and cancer. Cell 2016; 166: 555-566.
Wai T, Teoli D, Shoubridge EA. The mitochondrial DNA genetic bottleneck results from replication of a subpopulation of genomes. Nat Genet 2008; 40: 1484-1488.
Wallace DC, Chalkia D. Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease. Cold Spring Harb Perspect Biol 2013 5: a021220.
Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005; 39: 359-407.
Wang Y, Liu VW, Xue WC, Tsang PC, Cheung AN, Ngan HY. The increase of mitochondrial DNA content in endometrial adenocarcinoma cells: A quantitative study using laser-captured microdissected tissues. Gynecol Oncol 2005; 98: 104-110.
Warburg O. On the origin of cancer cells. Science 1956; 123: 309-314.
Warburg O. Metabolism of Tumors. Arnold Constable; London, UK: 1930
Ward Patrick S and Thompson Craig B. Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate. Cancer Cell 2012; 21: 297-308.
Wei Guo, Denghua Yang, Hongbo Xu, Yang Zhang, Junwei Huang, Zheng Yang, Xiaohong Chen, Zhigang Huang. Mutations in the D-loop region and increased copy number of mitochondrial DNA in human laryngeal squamous cell carcinoma. Molecul Biol Rep 2013;40: 13-20.
Weissensteiner H, Pacher D, Kloss-Brandstatter A, Forer L, Specht G, Bandelt HJ, Kronenberg F, Salas A, Schand;ouml;nherr S. HaploGrep 2: mitochondrial haplogroup classification in the era of high-throughput sequencing. Nucleic Acids Res 2016; 44: W58–W63.
Wu CW, Yin PH, Hung WY, Li AF, Li SH, Chi CW, Wei Y-H, Lee H-C. Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer. Gen Chrom Cancer 2005; 44: 19-28.
Wu W and Zhao S. Metabolic changes in cancer: Beyond the Warburg effect. Acta Biochim Biophys Sin (Shanghai) 2013; 45: 18-26.
Xie C, Naito A, Mizumachi T, Evans TT, Douglas MG, Cooney CA,Fan C-Y, Higuchi M. Mitochondrial regulation of Cancer Associated Nuclear DNA Methylation. Biochem Biophys Res Commun 2007; 364: 656-661.
Yakes FM and Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA 1997; 94: 514-519.
Yu FY, Xu Q, Wu DD, Lau AT, Xu YM. The Prognostic and Clinicopathological roles of Sirtuin-3 in various cancers. PLoS One 2016; 11: e0159801.
Yu M, Shi Y, Zhang F, Zhou Y, Yang Y, Wei X, Zhang L, Niu R. Sequence variations of mitochon drial DNA D-loop region are highly frequent events in familial breast cancer. J Biomed Sci 2008; 15: 535-543.
Zhang J, Asin-Cayuela J, Fish J, Michikawa Y, Bonafe M, Olivieri F, Passarino G, De Benedictis G, Franceschi C, Attardi G. Strikingly higher frequency in centenarians and twins of mtDNA mutation causing remodeling of replication origin in leukocytes. Proc Natl Acad Sci USA 2003; 100: 1116-1121.
Zhang H, Mizumachi T, Carcel-Trullols J, Li L, Naito A, Spencer HJ, Spring PM, Smoller BR, Watson AJ, Margison GP. Targeting human 8-oxoguanine DNA glycosylase (hOGG1) to mitochondria enhances cisplatin cytotoxicity in hepatoma cells. Carcinogenesis 2007; 28: 1629-1637.
Zhang H, Xie C, Spencer HJ, Zuo C, Higuchi M, Ranganathan G, Kern PA,Chou MW, Huang Q,,Szczesny B, Mitra S, Watson AJ, Margison GP, Fan C-Y. Obesity and hepatosteatosis in mice with enhanced oxidative DNA damage processing in mitochondria. Am J Pathol 2011; 178: 1715–1727.
Zhu W, Qin W, Bradley P, Wessel A, Puckett CL, Sauter ER. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate ?uid. Carcinogenesis 2005; 26: 145-152.
Zong WX, Rabinowitz JD, White E. Mitochondria and cancer. Mol Cell 2016; 61: 667-676.</References>
</References>
</Journal>
</Article>
</ArticleSet>